Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy
NCT ID: NCT02927886
Last Updated: 2016-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
40 participants
INTERVENTIONAL
2016-11-30
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
G-POEM for Treatment of Refractory Gastroparesis
NCT02732821
Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study.
NCT02779920
Gastric Per Oral Endoscopic Myotomy (G-POEM) in Refractory Gastroparesis
NCT03126513
G-POEM for Refractory Gastroparesis After Esophagectomy With Gastric Pull-through
NCT06068127
Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis
NCT04434781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Per-oral Endoscopy Pyloromyotomy (G-POEM)
Per-oral endoscopy pyloromyotomy
Intrapyloric injection of botulinum toxin
Intrapyloric injection of Botulinum toxin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Per-oral endoscopy pyloromyotomy
Intrapyloric injection of Botulinum toxin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presenting a clinical refractory gastroparesis for\> 1 year, that is to say whose functional nonspecific symptoms persisting despite medical therapy (prokinetic) optimal.
* Having a calculation before inclusion GCSI score (Gastroparesis Cardinal Symptom Index) and a scan of the pathological gastric emptying finding gastroparesis older than 3 months.
* No history of gastric surgery (partial gastrectomy Sleeve gastrectomy, ...) or esophageal surgery
* Not having endoscopic gastric lesions (ulcers antro-pyloric cancer).
* Having no indication against anesthetic.
* Having consented to participate in the study.
* Affiliated with a social security scheme (beneficiary or assignee).
Exclusion Criteria
* Pregnant or breastfeeding
* Having an anesthetic against indication.
* Scan the normal gastric emptying
* Under curative dose anticoagulants whose suspension is inappropriate.
* Under dual anti-platelet aggregation whose suspension is inappropriate.
* Being unable to give informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine Geindre
Role: STUDY_DIRECTOR
Assistance Publique Hôpitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gastro-entérologie, Hôpital Nord ,Assistance Publique Hôpitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A01365-46
Identifier Type: OTHER
Identifier Source: secondary_id
2016-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.